Google News – Pharmaceuticals External News
Life Sciences & Pharma Articles
Google News – Pharmaceuticals External News
Bulls Take Control of Takeda Pharmaceuticals: Chart of the Day - Barron's
Google News – Biopharma External News
The people who stayed with the problem - Fierce Pharma
Industry News External News
Dadachanji group gets back into pharmaceutical glass packaging with Kaisha Pharma - BusinessLine
Google News – Pharmaceuticals External News
Ashburn's Quoin Pharmaceuticals Secures Up to $50 Million to Fund Its Rare Disease Pipeline Into 2029 - BioBuzz
Google News – Pharmaceuticals External News
DC’s Vanda Pharmaceuticals Wins EU Orphan Status for Its Rare Skin Disease Drug - BioBuzz
Google News – FDA (biotech/pharma) External News
FDA takes another look at botanical drugs - STAT
Google News – Biopharma External News
Regulatory Expectations Are Changing: 5 Issues Biopharma Leaders Are Grappling With in 2026 - BioBuzz
Google News – Clinical Trials External News
MRSA therapeutics market to reach $1.8bn across 7MM in 2034 - Clinical Trials Arena
Google News – Oncology External News
Hutchmed, GSK Ink $1.3B Cancer Drug Deal - contractpharma.com
Google News – FDA (biotech/pharma) External News
Fierce Pharma Asia—Roche, GSK, Novartis billion-dollar deals; More MFN sign-ups; Akeso’s OS win - Fierce Pharma
Google News – Pharmaceuticals External News
Tarsus Pharmaceuticals Completes Acquisition of Alkeus, Adds Gildeuretinol for Stargardt Disease to Pipeline - Quiver Quantitative
Google News – Pharmaceuticals External News
A potentially blinding eye disease has no FDA-approved therapy. Tarsus bought a company developing one. - Stock Titan
Google News – Pharmaceuticals External News
Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care - GlobeNewswire
Google News – Pharmaceuticals External News